Drug Trial Radar · NCT00002368
The Safety and Effectiveness of Nevirapine Plus Lamivudine Plus Other Anti-HIV Drugs
Last checked: Nov 19, 2026Latest source record: Jun 24, 2005 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,000
Actual
Start
Not stated
Primary completion
Not stated
Sponsor
- Lead sponsor
- Boehringer IngelheimBoehringer Ingelheim
- Sponsor type
- Industry
- First posted
- Aug 31, 2001
Design
- Study type
- Interventional
- Phase
- Phase 3
- Model
- Parallel
- Primary purpose
- Treatment
- Who can join
- All sexes, from 13 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the tolerance, safety, and effectiveness of Viramune in preventing clinical AIDS progression events or death when used in combination with Lamivudine and background nucleoside therapy.
Conditions
- HIV Infections
Interventions
NevirapineDrug
LamivudineDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
53 sites in 1 country. Site status is shown where the registry gives one.
Drug Research and Analysis Corp
Montgomery, Alabama
Dr G Michael Wool
Los Angeles, California
UCLA School of Medicine / Ctr for Research and Education
Los Angeles, California
AIDS Research Ctr / Palo Alto VA Health Care System
Palo Alto, California
AIDS Community Research Consortium
Redwood City, California
ViRx Inc
San Francisco, California
San Francisco Gen Hosp / UCSF AIDS Program
San Francisco, California
Harbor - UCLA Med Ctr
Torrance, California
Infectious Disease Specialists
Colorado Springs, Colorado
Denver Public Health
Denver, Colorado
Dr Miguel Mogyoros / Clinical Research Dept
Denver, Colorado
Wilmington Hosp
Wilmington, Delaware
Novum Inc
Washington D.C., District of Columbia
Anthony LaMarca
Fort Lauderdale, Florida
North Broward Hosp District
Fort Lauderdale, Florida
Dr Robert Schwartz
Fort Myers, Florida
McGregor Clinic / Lee County Public Health Unit
Fort Myers, Florida
P Andrew Coley
Jacksonville, Florida
Goodgame Med Group
Maitland, Florida
Infectious Disease Research Institute Inc
Tampa, Florida
Palm Beach Research Ctr
West Palm Beach, Florida
Dr John Pottage
Chicago, Illinois
Northwestern Univ / Division of Infectious Diseases
Chicago, Illinois
Rush Presbyterian / Saint Luke's Med Ctr / Infect Dis
Chicago, Illinois
Indiana Univ Med School
Indianapolis, Indiana
Dr Daniel H Gervich
Des Moines, Iowa
Univ of Iowa
Iowa City, Iowa
Univ of Kentucky Med Cntr / Dept of Med / Div of ID
Lexington, Kentucky
Med Research Ctr
New Orleans, Louisiana
New England Med Ctr
Boston, Massachusetts
Beth Israel Hosp / Virology Research Clinic
Boston, Massachusetts
New England Deaconess Hosp
Boston, Massachusetts
International Medicine and Infectious Disease
Minneapolis, Minnesota
Trinity Lutheran Hosp / HIV Program
Kansas City, Missouri
Infectious Disease Associates of Central New Jersey
Somerville, New Jersey
SUNY / Erie County Med Ctr at Buffalo
Buffalo, New York
Dr David Kaufman
New York, New York
Saint Vincent Med Ctr
Staten Island, New York
Associates in Med and Mental Health
Tulsa, Oklahoma
The Research and Education Group
Portland, Oregon
Showing 40 of 53 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.